Tag: Development Velocity

The pharmaceutical industry invests heavily in technologies—$57.4 billion in 2022 alone—to discover new therapies to treat our greatest health challenges. Yet drug development teams are still using the same antiquated, manual processes to move those life-changing therapies toward commercialization.

By Donna Conroy, MS, published in Clinical Researcher

Development Velocity is the speed a pharmaceutical company moves a therapy through the development process and into the market.